Kenya is among the four countries in Africa that have been selected to participate in the Covid-19 vaccine trials.
This is according to African special envoys on Covid-19 and the Director of Africa CDC Dr. John Nkengason.
Dr. Nkengason made the announcement as he was speaking during a virtual meeting of the African Bureau convened to discuss the continental response to the Covid-19 pandemic.
He noted that seven vaccine trials were almost getting approved by the World Health Organization (WHO), and once they are done, the vaccines will be ready for trial.
Dr. Nkengason also said that Africa targeted to vaccine 60 percent of her population at approximately Sh 1 Trillion to Sh 1.5 Trillion once the vaccine is approved.
In a report, the director informed the leaders that despite crossing the 1 million mark in the number of infections, the continent had witnessed a 37 percent reduction in the daily infections in the last two weeks.
On his part, President Uhuru Kenyatta said that Africa needed to increase its partnerships globally in search of the virus vaccine.
Speaking on behalf of the East African Community (EAC) and Sothern African Development Community (SADC) Rwanda President Paul Kagame and his Mozambique counterpart Filipe Nyusi echoed President Kenyatta’s sediments emphasizing the need to ensure Africa is not marginalized and left behind in the roll-out of the vaccines once they are ready.
Uhuru commended the special envoys for their efforts to help the continent deal with the pandemic’s health and socioeconomic effects.
In July, Russian scientists at Sechenov University clinical research center made progress in developing a vaccine after they successfully crossed phase 1 of the human trials.
Also, in July, the co-founder of the Bill and Melinda Gates Foundation, Melinda Gates, said that her organization would ensure frontline healthcare workers across the globe, including Kenya, would be among the first to receive the Covid-19 vaccine as soon as the WHO approves it.